Related Experiment Videos
Growth regulatory factors and carcinogenesis: the roles played by transforming growth factor beta, its receptors and
1Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha 68198-6805, USA.
Abstract:
It is widely recognized that growth factors play critical roles in cell proliferation and differentiation. In the early 1980s, several members of the transforming growth factor-beta (TGF-beta) superfamily were identified and subsequently shown to play important roles in many diseases, in particular cancer. Efforts to understand how TGF-beta exerts its effects led to identification of TGF-beta-receptors and several downstream signaling pathways activated by this family of growth factors. This review provides an overview of TGF-beta-receptors and its downstream signaling pathways. As part of this discussion, this review indicates that inactivation of TGF-beta-receptors or components of their signaling pathways is often a target during carcinogenesis and that mutations or altered expression at any step along this complex, growth regulatory pathway can lead to aberrant cell proliferation. Lastly, the Cancer Genome Anatomy Project is briefly discussed, in particular how it may help to identify aberrant growth factor expression during carcinogenesis and improve the diagnosis of cancer patients.
Insights
Transforming growth factor-beta (TGF-beta) signaling is crucial for cell growth and cancer. Aberrant TGF-beta receptor or pathway signaling contributes to cancer development and progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Growth factors regulate cell proliferation and differentiation.
- Transforming growth factor-beta (TGF-beta) superfamily members are implicated in various diseases, notably cancer.
- Understanding TGF-beta's mechanisms involves studying its receptors and downstream signaling.
Purpose of the Study:
- To provide an overview of TGF-beta receptors and their downstream signaling pathways.
- To highlight the role of TGF-beta pathway dysregulation in carcinogenesis.
- To discuss the potential of the Cancer Genome Anatomy Project in cancer diagnosis.
Main Methods:
- Literature review of TGF-beta signaling pathways.
- Analysis of the role of TGF-beta receptors in cancer.
- Discussion of cancer genomics initiatives.
Main Results:
- TGF-beta receptors and signaling pathways are critical for cell growth regulation.
- Inactivation of TGF-beta receptors or signaling components is a common event in cancer.
- Mutations or altered expression in the TGF-beta pathway can lead to uncontrolled cell proliferation.
- The Cancer Genome Anatomy Project may aid in identifying aberrant growth factor expression.
Conclusions:
- Dysregulation of the TGF-beta signaling pathway is a key mechanism in cancer development.
- Targeting the TGF-beta pathway offers potential therapeutic strategies.
- Genomic projects can enhance cancer diagnosis and identify novel therapeutic targets.